Roche and Genentech announce new clinical trial to begin early next year - Generation HD2 - to explore the use of tominersen in younger, less symptomatic HD patients. Click here…
Drug trial shows promising results to fight Huntington’s disease
New CNN report reveals promising trial to help fight Huntington's disease. Read more from CNN here.
Novel Compound Has Promise for Treatment of Huntington’s Disease
Mass. General-led study identifies molecular compound with two neuroprotective activities. Please join us in congratulating HD-CARE Scientific Advisory Board members, Dr. Malcolm Casale and Dr. Leslie Thompson and Dr. Ryan…